Search Results for: weekly reads

Weekly reads: De-extinction pros & cons with Dodo 2.0, CTCF, retraction

Dodo bird de-extinction, de-extinction

I don’t think de-extinction of animals just for the heck of it like woolly mammoths is a good idea, but what about de-extincting animals like the Dodo? Where humans caused them to disappear? If that’s even possible, is it a good idea? Dodo de-extinction A company is giving it a try. I can see the …

Weekly reads: De-extinction pros & cons with Dodo 2.0, CTCF, retraction Read More »

Weekly reads: ChatGPT as author, COVID pub concern, CRISPR kit

Sam Altman, OpenAI, Chat GPT

Have you had the chance to play around on ChatGPT, the open AI? It can “talk” to you in text kind of like a person. I have tried it out. It’s quite interesting to type in scientific questions and see what pops out. Often it is high-quality text and solid ideas, but not always. You …

Weekly reads: ChatGPT as author, COVID pub concern, CRISPR kit Read More »

Weekly reads: H3.3 on the brain, Texas bill, HSCs

H3f3a, histone H3.3, knockout

It’s always exciting when your lab has a new paper and my team just published a study knocking out the H3f3a gene in mice, which codes for histone H3.3 protein. We found that loss of this gene leads to lethality at a late stage of embryonic development. There were also indications of more specific phenotypes …

Weekly reads: H3.3 on the brain, Texas bill, HSCs Read More »

Weekly reads: reprogramming aging, astrocytes, cartilage, ChatGPT

Let’s start with a couple of new pieces on in vivo reprogramming. The idea here is to do something like making iPS cells but doing it inside organisms and not quite pushing cells all the way back to pluripotency. Just younger, healthier cells. Why do that? The goal is to achieve a kind of anti-aging …

Weekly reads: reprogramming aging, astrocytes, cartilage, ChatGPT Read More »

Weekly reads: stem cell good news, bad news on sickle cell, MS, IPSCs

victoria gray family crispr sickle cell b

Let’s start with some stem cell good news on evolving approaches to treat sickle cell disease involving stem cells. Then on another related front things were more concerning. Stem cell good news on sickle cell disease, a complication Sickle Cell Disease News reports Adding Briquilimab Boosts Success of Sickle Cell Stem Cell Transplant. This is a …

Weekly reads: stem cell good news, bad news on sickle cell, MS, IPSCs Read More »

Weekly reads: CRISPR chicks, HSCs, sequencing Mendel

CRISPR chicks

I tend to perhaps over-focus on human CRISPR or gene editing, but other applications including in agriculture are definitely going to be huge. CRISPR in agriculture One that I’ve been following for a long time is the use of CRISPR to prevent cows from growing horns. Why is that a big deal? Just in the …

Weekly reads: CRISPR chicks, HSCs, sequencing Mendel Read More »

Weekly reads: Kevin McCormack passes, HSCs & RXR, Ethics

Kevin McCormack, Paul Knoepfler, stem cell research

Out of the blue this past week we lost Kevin McCormack of CIRM to a heart attack. When I first heard, my reaction was that can’t be, but it is. About Kevin McCormack If you aren’t familiar with him, Kevin was officially Director of Patient Advocacy at our state’s Stem Cell Agency. However, he was …

Weekly reads: Kevin McCormack passes, HSCs & RXR, Ethics Read More »

Weekly reads: Marc Tessier-Lavigne probe, Neuralink on the brain, Ras unchained

Marc Tessier-Lavigne

We’ll start with a story related to possible research misconduct, Stanford’s President Marc Tessier-Lavigne, and Science Magazine.  In some ways the news on Science itself could be the bigger long-term story. Marc Tessier-Lavigne pub investigation, Science oops moment Here’s some of the coverage: Stanford investigates potential misconduct in president’s research, Science. Multiple publications of Marc Tessier-Lavigne …

Weekly reads: Marc Tessier-Lavigne probe, Neuralink on the brain, Ras unchained Read More »

Weekly reads: Gamida Cell, Siddhartha Mukherjee, CRISPR in viruses

Abigail L. Jenkins, Gamida Cell

Hematopoietic stem cells have many clinical applications and a company called Gamida Cell has an interesting product in this area called Omidubicel that may have several applications.  I’m going to start the weekly reads with news there. Gamida Cell and the FDA A recent piece discussed how Omidubicel is progressing with the FDA. FDA extends …

Weekly reads: Gamida Cell, Siddhartha Mukherjee, CRISPR in viruses Read More »

Weekly reads: NurOwn, key gene screen, MS, Croce mess

Nurown BrainStorm

I get a lot of questions about stem cells for ALS and more recently people have been specifically interested in NurOwn from BrainStorm Cell Therapeutics. Recently, the FDA denied BrainStorm’s request for a BLA for NurOwn. The company felt its Phase III trial was encouraging. It sounds like they will move forward with a follow-up …

Weekly reads: NurOwn, key gene screen, MS, Croce mess Read More »